Diabetes Flashcards

1
Q

Why does insulin response to oral glucose exceed response to IV glucose?

A
  • Incretin Hormones (i.e. GLP-1)
  • synthesized in L cells of ileum and colon in response to incoming nutrients
  • stimulate insulin secretion, suppress glucagon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is first-line treatment along with lifestyle interventions at the time of type 2 diabetes diagnosis? Mechanism?

A

Metformin

–> Activates hepatic AMP-kinase; decreases hepatic glucose production (decreases overnight fasting glucose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the advantages and disadvantages of Metformin therapy?

A

Advantages: no weight gain, no hypoglycemia; reduction in cardiovascular events and mortality; cheap
Disadvantages: GI side effects (usually transient), lactic acidosis (rare) - contraindicated in renal disease; Vit B deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 4 Sulfonylureas? Mechanism?

A
Glipizide (Glucotrol)
Glyburide 
Glimepiride
Gliclazide 
-->Closure of ATP-sensitive K+ channels on β-cell plasma membrane --> stimulation of insulin release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the advantages and disadvantages of Glyburide and those in its class?

A

(sulfonylureas- stimulate insulin release)
Advantages: Reduction in cardiovascular events and mortality; cheap
Disadvantages: Weight gain; hypoglycemia (since glucose-independent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 2 Meglitinide agents? Mechanism?

A

Repaglinide
Nateglinide
–> Closure of ATP-sensitive K+ channels on β-cell plasma membrane –> stimulation of insulin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 2 classes that stimulate insulin secretion? What is the major difference?

A

Sulfonylureas & Meglitinides

  • -> Meglitinides are more rapid-acting with a shorter duration and taken before each meal (less risk hypoglycemia); also cost more
  • ->Sulfonylureas are taken once a day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are 2 Thiazolidinediones that activate PPAR in Diabetes management? Mechanism? Which one has an increased risk of bladder cancer and which is contraindicated in heart disease?

A

Pioglitazone - (bladder cancer)
Rosiglitazone - (heart disease)
–>Binds PPAR-γ, a nuclear transcription factor; increases peripheral insulin sensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are 2 α-glucosidase inhibitors? Mechanism? What is the main side effect?

A

Acarbose
Miglitol
–> Taken with each meal to competitively inhibit break down of carbohydrates into simple sugars, delaying GI carbohydrate absorption & reducing postprandial glucose levels
-SE: GI- gas, flatulence, diarrhea (more popular in elderly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are 2 Diabetic agent classes that increase incretin effects? Mechanism and effect?

A

GLP-1 agonists (incretin memetics)
DPP-4 inhibitors (prevents degradation of GLP-1)
-Increase insulin secretion
-decrease glucagon secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 2 incretin mimetics? Advantages and Disadvantages?

A

(GLP-1 agonists)
Exenatide
Liraglutide
-Advantages: Leads to weight reduction (increases satiety, slows gastric emptying) ; may improve β-cell mass
-Disadvantages: Acute pancreatitis; GI (nausea, vomiting, diarrhea); expensive & injection only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 4 DPP-4 inhibitors? Advantages, Disadvantages?

A

Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
-Advantages: No hypoglycemia, weight neutrality
-Disadvantages: Urticaria/angioedema; pancreatitis; expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What Diabetic agent reduces glucose reabsorption in the kidney? Advantages and Disadvantages?

A

Canagliflozin (SGLT2 inhibitor)

  • Advantages: No hypoglycemia; weight loss possible
  • Disadvantages: UTIs; genital mycotic infections; volume depletion; hyperkalemia; hypersensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which agent may be given if patient is diabetic and also hyperlipidemic? Mechanism? Advantages and Disadvantages?

A

Colesevelam (Bile acid sequestrant)

  • Advantages: No hypoglycemia; decreased LDL cholesterol
  • Disadvantages: Increase in triglycerides; constipation; may interfere with absorption of other medications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a diabetic agent that is rarely used and works by altering hypothalamic regulation of metabolism increasing insulin sensitivity?

A

Bromocriptine (Dopamine-2 agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which diabetic agent is injected in combination with short or rapid-acting insulin before each meal? Mechanism? What’s a significant risk? SE?

A

Pramlintide (amylin analog)

  • -> Mimics amylin: slows gastric emptying, suppresses postprandial glucose secretion, may reduce appetite
  • hypoglycemia is significant risk
  • SE: GI side effects (especially nausea)
17
Q

What are the least expensive insulin agents available that are often used together? Disadvantages?

A

Regular - short-acting
NPH - intermediate acting
-Regular 3x (bfast, lunch, dinner) and NPH 1x at bedtime
or
-Regular 2x (bfast, dinner) and NPH 2x (bfast, dinner)
[greater likelihood of nocturnal hypoglycemia or fasting hyperglycemia]

18
Q

What are 3 rapid-acting insulin agents? Onset, peak and duration times?

A

Lispro
Aspart
Glulisine
OoA: 5-30 min; PA: 0.5-3 hrs; DoA: 3-5 hrs

19
Q

What is the onset, peak and duration times of regular insulin?

A

(short-acting)

OoA: 30-60 min; PA: 1-5 hrs; DoA: 6-8 hrs

20
Q

What are 4 intermediate-acting insulin agents? Onset, peak and duration times?

A

NPH; NPL; NPA
OoA: 1-4 hrs; PA: 4-10 hrs; DoA: 14-24 hrs
Detemir (duration is dose-dependent)
OoA: 3-4 hrs; PA: 4-8 hrs; DoA: 6-24 hrs

21
Q

What are 2 agents that can be used as basal insulin? What is important about these agents?

A

Detemir (at high doses DoA can reach 24hrs)
Glargine (OoA: 2-3 hrs; PA: none; DoA: 24-30 hrs)

–should not be mixed with other insulin preparations

22
Q

What is the most common insulin agent concentration? What concentration is used for severe insulin resistance?

A

Most common- U-100 (100 units insulin/ml)

Severe insulin resistance- U-500

23
Q

What is the only insulin agent that may be used to treat diabetic ketoacidosis?

A

Regular Insulin

  • only agent that can be given IV
  • plasma half-life <9min
24
Q

Premixed Insulins are rarely used in type 1 diabetes- what are the disadvantages of premixed agents?

A
  • loss of flexibility matching carbohydrate intake and physical activity
  • harder to treat short-term high or low blood glucose
  • hypoglycemia risk
25
Q

What is the treatment for hypoglycemia in the hospital setting? and in the home setting?

A

In both cases, if patient is able they should ingest glucose (pill or food)
If patient in hypoglycemic coma:
-Hospital: IV dextrose
-Home: glucagon injection by caregiver

26
Q

What are some side effects of Aspart and those in its class?

A

(insulin agents)

  • hypoglycemia
  • weight gain (glycosuria reduced, fuel-storage mechanisms restored, overeat due to fear of hypoglycemia)
  • lipoatrophy (at site of injection; uncommon)
  • lipohypertrophy (need to rotate site of injection to prevent)
27
Q

What is the only type of insulin used in pump therapy?

A

rapid-acting:
insulin delivered every few minutes in small amounts with bolus doses for meals
(lispro, aspart, glulisine)

28
Q

What is continuous glucose monitoring?

A

SQ electrochemical sensor measures interstitial glucose and sends information to transmitter and pump every 5 minutes where data can be viewed and acted on in real-time; alarms when low/high